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Purpose: Evidence that indicates bile acid is a promoter of colon cancer exists. Deoxycholic acid (DCA) modifies apoptosis 
or proliferation by affecting intracellular signaling and gene expression. However, because previous studies have been based 
on studies on colon cancer cell lines, the effect of DCA on normal colonocytes is unknown.
Methods: Normal colonocytes and Caco-2 and HCT116 cells were treated with 20 μM and 250 μM of DCA, and the effect of 
different concentrations of DCA was measured based on the expression of cell-cycle-related proteins by using Western blots. 
Results: The expressions of CDK2 and cyclin D1 for different concentrations of DCA in normal colonocytes and colon can-
cer cells were similar, but the expressions of cyclin E and A were significantly different. In HCT116 colon cancer cells, the 
expression of cyclin E increased regardless of the DCA concentration, but in normal colonocytes and Caco-2 cells, the ex-
pression of cyclin E was not changed or decreased. In HCT116 colon cancer cells, the expression of cyclin A was not changed 
or decreased regardless of the DCA concentration, but in normal colonocytes and Caco-2 cells, the expression of cyclin A 
was increased at a DCA concentration of 20 μM. 
Conclusion: The effect of DCA on stimulating cell proliferation suggests that DNA synthesis is stimulated by an increased 
expression of cyclin E in colon cancer cells. Our results suggest that a low dose of DCA induces cellular proliferation through 
increased expression of cyclin A and that a high dose of DCA induces decreased expression of cyclin E and CDK2 in nor-
mal colonocytes.
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with added deoxycholic acid (DCA) showed a more tumor 
than the control group with just AOM treatment [2-4]. In ad-
dition, by changing the flow of cholic acid of a mouse through 
operation and treating with AOM, Morvey [5] reported that 
large intestine, which was not exposed to cholic acid, showed 
very few or almost no tumors when compared with the large 
intestine exposed to cholic acid.
Secondary bile acid, such as DCA, is well known to be a tu-
mor facilitating factor that will induce exfoliation of epithelial 
cells from the surface of the large intestine mucosa when pres-
ent in concentrations of 2-5 mM. Through a compensatory 
mechanism, hyperplasia of large intestine epithelial cells will 
occur and facilitate tumor development [6, 7]. According to 
other studies, a low concentration of secondary bile acid in-
creases the number of aberrant crypt foci (ACF) [3] in the large 
intestine, and DCA in concentrations greater than 50 μM will 
cause colon cancer cell death. The studies demonstrated that, 
according to these effects of DCA in low concentrations, cell 
death caused by cholic acid will play a crucial role in facilitat-
ing tumor development in the large intestine [8]. However, 
the mechanism explaining how DCA or other cholic acids act 
is not yet clearly understood. There are reports about the tu-
INTRODUCTION
Epidemiological investigation found that an increase in fecal 
cholic acid is a risk factor and facilitates the development of 
colon cancer [1, 2]. Also, increased levels of cholic acid con-
centration in the stool and blood were found in patients with 
a large intestine adenoma. These results indicate that an in-
creased level of cholic acid in the stool has a relationship with 
colon cancer development [1]. However, the strongest proof 
that cholic acid is related with colon cancer development can 
be found in the animal model for treating a tumor in the large 
intestine with azoxymethane (AOM). The group that had food 
Received: March 1, 2010     Accepted: June 29, 2010
Correspondence to: Dong-Guk Park, M.D.
Department of Surgery, Dankook University School of Medicine, San 16-5 
Anse-dong, Dongnam-gu, Cheonan 330-715, Korea
Tel: +82-41-550-3931, Fax: +82-41-565-6167
E-mail: dkpark@dankook.ac.kr
© 2010 The Korean Society of Coloproctology
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of the Korean Society of
Coloproctology
www.coloproctol.org 255
Volume 26, Number 4, 2010
J Korean Soc Coloproctol 2010:26(4);254-259
mor-facilitating effect affecting intracellular signal transduc-
tion and gene expression and eventually causing cell death or 
altered cell proliferation.
DCA activates AP-1, and activation of protein kinase C (PKC) 
and mitogen-activated protein kinase (MAPK) is necessary for 
AP-1 activation [9]. MAPK is an important signal transduction 
factor that delivers various extracellular stimuli to the inside of 
the cell, which controls cell proliferation, differentiation, and 
death. Most of the transportation of extracellular signals to the 
nucleus at the cell membrane is done by three types of MAPKs: 
extracellular signal-regulated kinase (ERK), c-Jun N-terminal 
kinase (JNK), and p38 MAP kinase (p38). Although DCA acti-
vates both ERK and p38, only the ERK activated by DCA affects 
cell death caused by DCA. However, there are reports that have 
showed that increased activation of ERK by DCA suppressed 
cell death caused by DCA [10]. These reports convey the ideas 
that DCA has the function of stimulating cell hyperplasia and 
cell death and that high concentrations of DCA generally in-
duce cell death. However, the mechanism for or the cause of 
DCA inducing cell hyperplasia or cell death is still unknown.
In order for cholic acid to induce large-intestine epithelial-
cell deformation or cancer development, the epithelial cell must 
be exposed to cholic acid for a long period of time. Prevention 
of cancer caused by cholic acid would be possible if the mech-
anism of a normal mucosa epithelial cell turning into cancer 
is discovered. Since the researchs until now used colon cancer 
strains, it was difficult to say that DCA reflected the action of 
a normal large-intestine mucosa epithelial cell. Thus, this re-
search was conducted by separating and culturing normal 
large-intestine mucosa cells. The normal large-intestine mu-
cosa cells were then compared with cells of the Caco-2 colon 
cancer strain (containing the characteristics of normal cells) 
through a study of the variations in cell-cycle protein expres-
sion with changing DCA concentration. The results were com-
pared with the expressions from the HCT116 colon cancer cell 
strain to search for the effect of DCA on the protein-expres-
sion-related cell cycle.
METHODS
Materials and antibodies
The antibodies used in this experiment were CDK2 (M2, 1 : 
1,000, anti-goat polyclonal antibody against a peptide mapping 
at the carboxy terminus of CDK2), cyclin D1 (C-20, mAb), cy-
clin E (HE-12, mAb and C-19 pAb), and cyclin A (C-19), which 
were purchased from Santa Cruz Biotechnology (Santa Cruz, 
CA, USA). The culture medium used in the cell culture was 
RPMI1640 (JEIL Biotech Services Incorp, Daegu, Korea), and 
fetal bovine serum (FBS, Hyclone Laboratories, Logaar, UT, 
USA), penicillin-streptomycin, and deoxycholate (Sigma, St 
Louis, MO, USA) were added reagents. The PVDF membrane, 
the SDS-PAGE electrophoresis apparatus, and the semi-dry 
membrane transfer equipment were purchased from Bio Rad 
(Hercules, CA). All other reagents were purchased from Sigma 
Biochemical. The HCT116 colon cancer cell strain and the 
Caco-2 colon cancer cell strain, which is known to have nor-
mal large-intestine mucosa-cell properties, were purchased 
from the Korean Cell Line Bank.
Separating and culturing normal large intestine mucosa cells
Samples of normal large-intestine mucosas were collected dur-
ing surgery for colon cancer or benign large-intestine disease, 
and the samples were collected at least 5 cm from the lesion 
site. The samples were separated with caution in order to pre-
vent muscle cells underneath the mucosa and the submucosal 
layer from being included. Blood vessels in the submucosal 
layer and connective tissue were removed from the sample. 
The mucosal sample was then immediately placed in 50 mL of 
chilled, ice cold, Hank’s Balanced Salt Solution (HBSS, 100 U/
mL PCN-SM, 50 μg/mL GM, 2.5 μg/mL Amphotericin B, with-
out Ca
+2, Mg
+2). Lipid and necrotic tissue were removed and 
the sample was cut into 3- to 4-mm-sized strips. Then, the 
samples were washed with HBSS several times. Fifty mL of 
HBSS (1 mM DTT, 1 mM EDTA, 100 U/mL PCN-SM, 50 μg/
mL Gentamicin, 2.5 μg/mL Amphotericin B, without Ca
+2, 
Mg
+2) was placed in a beaker, and magnetic stirring bar was 
used at room temperature for 30 minutes at a speed of 0.3 g to 
remove the remaining mucous and sludge. The stirring speed 
was controlled in order for all the epithelial cells to float in the 
fluid. After cleaning the epithelial cells with HBSS, the sample 
was once more stirred and reacted with 100 mL of HBSS (1 mM 
EDTA, 100 U/mL PCN-SM, 50 μg/mL Gentamicin, 2.5 μg/mL 
Amphotericin B, without Ca
+2, Mg
+2) without DTT at room 
temperature for 60 minutes. Supernatant-containing crypts 
were collected at least twice, and the crypts were set on top of 
ice to let them settle quickly. Collected crypts were washed 
with RPMI culture fluid containing the same antibiotics. Then, 
a suspension containing 15 mL of RPMI culture fluid and 10% 
fetal bovine serum was created before culturing. Two hundred 
U/mL of collagenase (Sigma type I) and 270 U/mL of DNase 
were added to the separated crypt samples and were reacted 
for 60 minutes at 37°C. Separated large-ntestine epithelial cells 
were cultured in RPMI culture fluid containing 10% fetal bo-
vine serum.
Deoxycholic acid treatment
The concentration of DCA in the experiment was determined 
by using the MTS method, and the survival rates of the HCT116 
colon cancer strain were measured when different concentra-
tions of DCA were added and cultured for 3 days. Twenty μM 
and 250 μM were used as concentration values. Separated nor-
mal large-intestine epithelial-cell samples were treated with 
DCA in different concentrations and were cultured for 24 hours. 
As a control group, one sample was cultured for 24 hours with-Journal of the Korean Society of
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out adding DCA. The Caco-2 strain and the HCT116 colon 
cancer strain were cultured in the same way to compare their 
results with those for normal large-intestine epithelial cells.
Measuring expression of proteins related to the cell cycle by 
using western blots
The cell samples were cultured for 24 hours (72 hours for the 
Caco-2 strain) at each concentration of DCA and were wash   
ed with cooled 0.1 M PBS (8.5 mM Na2HPO4•7H2O, 3 mM 
KH2PO4, 125 mM NaCl) 3 times. Cells were dissolved in cell 
lysis buffer solution (25 mM Tris-Cl [pH 7.0], 1 mM EDTA,   
1 mM PMSF, 1 mg/mL leupeptin, antipain, aprotinin 0.1% NP-
40, 250 mM NaCl, 5 mM DTT, 0.1% Triton-X-100). Cell ho-
mogenate went through the centrifuge at 12,000 rpm for 15 
minutes at 4°C. Then, the supernatant was separated and stored 
at -80°C before being used. Protein quantification was mea-
sured using the Bradford micro-assay method.
Thirty μg of cell lysate was added to each Laemmli sample 
buffer (0.5 M Tris-HCl [pH 6.8], 10% glycerol, 2% [w/v] SDS, 
5% [v/v] 2-β-mercaptoethanol and 0.05% bromophenollue) 
and was degenerated at 95-100°C for five minutes by boiling. 
Each of the specimens went through electrophoresis in 10% 
polyacrylamide gel by using the Laemmli method. Separated 
proteins were moved to a nitrocellulose membrane by using 
the semi-dry transblot apparatus. This membrane was placed 
in a solution with 5% non-fat skim milk dissolved in 1% TBS 
with 0.1% Tween-20 buffer (Tris 50 mM, 250 mM NaCl, 0.1% 
Tween-20, pH 7.5) was allowed to sit overnight at 4°C. The pri-
mary antibody mentioned above was dissolved in 1% TBS with 
0.1% Tween-20 buffer solution overnight in the ratio of 1 : 
1,000 at 4°C. After the primary antibody reaction, the sample 
was washed three times in 1% TBS-T for 10 minutes each. 
Then, it was reacted with peroxidase-conjugated secondary 
antibody (anti-mouse for monoclonal antibody, anti-goat for 
polyclonal antibody, 1 : 2,500 dissolved, Zymed Laboratories 
Inc, San Francisco, CA, USA) for 1 hour at room temperature. 
It was then re-washed three times with 1% TBS-T for 10 min-
utes each wash. Remaining immunoreactive protein was reacted 
by using a chemiluminescence kit (ECL kit, Amersham Co. 
Uppsala, Sweden) and following the manufacturer’s directions, 
and immunological reaction strips were detected with an im-
age analyzer (LAS-2000, Fuji, Tokyo, Japan). ERK protein ex-
pression was used as a control for internal protein expression.
RESULTS
When a 50 μM, 200 μM or 250 μM concentration of DCA was 
added to the HCT116 colon cancer cell strain and cultured for 
72 hours, at the 200- and 250 μM concentrations, colon can-
cer strain proliferation was suppressed. However, for 50 μM 
of DCA, the proliferation of the strain was increased when com-
pared with the control group without DCA added. In deciding 
the concentration of DCA, we used the MTS method to mea-
sure the toxicity of DCA. There was no cytotoxicity until the 
concentration of DCA reached 100 μM. In concentrations 
greater than 250 μM, approximately half of the colon cancer 
cells showed cytotoxicity when cultured for 72 hours. Although 
normal large-intestine epithelial cells should be used to mea-
sure the effects of DCA (cell proliferation and cytotoxicity), 
the effects were impossible to measure after culturing for 72 
hours because 50% of the normal large-intestine epithelial cells 
survived after culturing for 24 hours without adding DCA. As 
an alternative, HCT116 colon cancer cells were used to deter-
mine the effects of DCA in different concentrations, and the 
results were used as standards. Twenty μM DCA was used as 
a low concentration, and 250 μM was used as a high concentra-
tion. Each was cultured for 24 hours, and changes in cell-cy-
cle-related protein expression caused by DCA were measured.
When normal large-intestine epithelial cells (Fig. 1) were cul-
tured for 24 hours, a prominent decrease in the number of cells 
was found even without adding DCA. A similar cell count de-
crease was measured in the colon cancer cell group with 20 μM 
DCA. Even in colon cancer cells where approximately 50% of 
A
B C
D E
Fig. 1. Isolated human colonic crypt (A) and colonocytes (B). Human 
normal colonocytes were incubated for 24 hours with various concen-
tration of deoxycholic acid: 0 (C), 20 μM (D), and 250 μM (E).Journal of the Korean Society of
Coloproctology
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the cells showed cytotoxicity, most of the large-intestine epi-
thelial cells showed cell death when 250 μM of DCA was added 
(Fig. 1).
After culturing for 24 hours, expression of cell-cycle-related 
protein was measured by using the Western blot method (Figs. 
2 and 3). In normal large-intestine epithelial cells, independent 
of the DCA concentration, there was no change in cyclin D1 
expression. No cyclin D1 expression was found in Caco-2 cells. 
Expression of CDK2 did not change in the 20 μM DCA group, 
but there was a decrease in the 250 μM DCA group. The same 
expression pattern was found in Caco-2 cells. Expression of 
cyclin E did not show any change after culturing for 24 hours, 
independent of the concentration of DCA. In Caco-2 cells, no 
noticeable change of expression was measured when 20 μM   
of DCA was added, but a significant decrease was measured 
when 250 μM of DCA was added. Expression of cyclin A was 
increased for a concentration of 20 μM, but did not change 
when 250 μM of DCA was added. Caco-2 cells, however, show- 
ed the same pattern as that shown by normal large-intestine 
epithelial cells (increased expression at 20 μM), but no expres-
sion was measured at 250 μM of DCA.
Expressions of cell-cycle-related protein in normal large-in-
testine epithelial cells with DCA are compared with expressions 
in HTC116 colon cancer cells (Figs. 4-7). In colon cancer cells, 
an increase of cyclin E expression was measured in groups with 
added DCA independently of the DCA concentration when 
compared with the group with no DCA added. However, no 
change in expression was found in normal large-intestine epi-
thelial cells, and this result was independent of the DCA con-
centration (Fig. 4). CDK2 expression in colon cancer cells was 
slightly reduced or did not change; showing the same results 
as those for normal large-intestine epithelial cells or Caco-2 
cells (Fig. 5). There was no change in expression of the cyclin 
A protein in colon cancer cells cultured for 24 hours in 20 μM 
DCA. However, no expression was found when 250 μM DCA 
was added. In the case of normal large-intestine epithelial cells, 
an increase of cyclin A expression was measured for 20 μM 
DCA, but no change in expression was measured for 250 μM 
DCA (Fig. 6). Expression of cyclin D1 protein in colon cancer 
cells did not change when 20 μM DCA was added, but no ex-
pression was measured when 250 μM DCA was added. How-
ever, normal large-intestine epithelial cells did not show any 
Fig. 2. Change of cell-cycle-related proteins in human colonocytes 
after incubation for 24 hours with deoxycholic acid based on a West-
ern blot analysis. Conc., concentration; ERK, extracellular signal-reg-
ulated kinase. 
CDK2 (M2)
  0  0  20  250    Conc. (μM)
Cyclin E (HE12)
Cyclin A (C-19)
Cyclin D1 (A-12)
ERK (C-20)
Fig. 3. Comparison of the change in cell-cycle-related proteins in the 
Caco-2 colorectal cancer cell-line after incubation for 72 hours with 
deoxycholic acid based on a Western blot analysis. Conc., concentra-
tion; ERK, extracellular signal-regulated kinase. 
CDK2 (M2)
  0  0  20  250          Conc. (μM)
0 hr 72 hr
Cyclin E (HE12)
Cyclin A (C-19)
Cyclin D1 (A-12)
ERK (C-20)
  0  0  20  250  (μM)
ERK (C-20)
Colonocytes
HCT116
Fig. 4. Comparison of the change in the cyclin E protein in human 
colonocytes and in HCT116 colon cancer cells after incubation for 
24 hours with deoxycholic acid based on a Western blot analysis. 
ERK, extracellular signal-regulated kinase. 
  0  0  20  250    (μM)
ERK (C-20)
Colonocytes
HCT116
0 hr 24 hr
Fig. 5. Comparison of the change of Cdk2 protein after incubation for 
24 hours with deoxycholic acid in human colonocytes and HCT116 
colon cancer cells by Western blot analysis. ERK, extracellular signal-
regulated kinase. Journal of the Korean Society of
Coloproctology
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change in the expression of cyclin D1, independent of the DCA 
concentration (Fig. 7).
DISCUSSION
Cholic acid, a derivative of cholesterol, is necessary for con-
trolling transcription of the gene that controls dietary fat ab-
sorption and cholesterol homeostasis. However, cholic acid 
can induce various biological effects depending on its differ-
ent chemical structures [8]. Ursodeoxycholic acid (UDCA), 
one of the hydrophilic cholic acids, protects and prevents cell 
death caused by other hydrophobic cholic acids [11]. DCA 
was chosen from among the various kinds of cholic acids for 
this experiment because DCA is known to have the strongest 
cytotoxicity [12].
For low concentrations of DCA (< 50 μM), cell proliferation 
of the HCT116 colon cancer strain was stimulated whereas 
concentrations greater than 200 μM induced cell death as the 
cells were detached from the culture flask, thus showing the 
two different effects (cell proliferation and cell death) that DCA 
has, depending on the concentration. According to other re-
search, these effects of DCA on colon cancer strains were also 
found in the Caco-2 strain (maintaining fetus’ normal large-
intestine mucous cells) [13] and the HT-29 colon cancer strain 
(undifferentiated cancer cells) [14]. These results match the 
data showing that the colon cancer strain proliferates in DCA 
lower than 5 μM [15] and dies in DCA higher than 50 μM [8]. 
According to the cytotoxicity measurements done with the 
MTS method, the cell survival rate decreases greatly when the 
DCA concentration is greater than 100 μM, thus showing sig-
nificant cytotoxicity. This measurement of the DCA concentra-
tion, however, was done using the colon cancer strain. For an 
accurate experiment, normal large-intestine epithelial cells must 
be used for testing cell proliferation and cytotoxicity caused 
by DCA. However, because of the low survival rate of normal 
large-intestine epithelial cells (< 50% when cultured for 24 
hours without DCA), testing cytotoxicity was impossible to 
measure after culturing for 72 hours. Thus, HCT116 colon can-
cer cells were used to set the standard for DCA concentration. 
Twenty μM and 250 μM were considered as the low concen-
tration and the high concentration of DCA, respectively. Cells 
were cultured for 24 hours, and changes in cell-cycle-related 
protein expression due to DCA were measured.
DCA showed four large-intestine epithelial-cell proliferation 
effects: 1) increased mutation of the k-ras gene in large-intes-
tine tumors [16], 2) increased expression of AP-1 (human colon 
cancer cell transcription factor) [9], 3) suppressed cell death 
caused by butyrate in cultured neoplastic large-intestine epi-
thelial cells [17], and 4) directly stimulated colon cancer cell 
movement [18]. However, a high concentration of DCA induces 
cell death in large-intestine cells [8-10]. All these effects are 
probably caused by DCA controlling the intercellular signal 
transduction system through PKC activation of the phobol es-
ter effect. Various kinds of cholic acids also suppress cell pro-
liferation and cell death in breast cancer cells. They also reduce 
expression of Bcl-2 and cyclin D1, but are reported to not have 
an effect on CDK2 and CDK4. Also, these effects on the cell cy-
cle are reported to be independent of p53 expression [19]. 
According an experimental result, CDK2 protein showed the 
same expression changes in normal large-intestine epithelial 
cells, the Caco-2 strain, and the HCT116 colon cancer strain 
when different concentrations of DCA were added. Cyclin D1 
either did not show any expression change or showed a slight 
decrease. Expression changes caused by DCA concentration 
between the HCT116 colon cancer strain and the normal large-
intestine epithelial cells were especially noticeable for cyclin E 
and cyclin A. Cyclin E expression was increased in the HCT116 
colon cancer strain, regardless of the concentration of DCA. 
On the other hand, it was either decreased or did not change 
in normal large-intestine epithelial cells and Caco-2 cells. Cy-
clin A protein expression showed either no change or a decrease 
in HCT116 colon cancer cells whereas an increase in expres-
sion was found in normal large-intestine epithelial cells and 
Caco-2 cells at 20 μM.
The proliferation effect of DCA did not include increased ex-
pression of cyclin D1 (curator of cell-cycle entrance from the 
  0  0  20  250    (μM)
ERK (C-20)
Colonocytes
HCT116
0 hr 24 hr
Fig. 6. Comparison of the change in the cyclin A protein in human 
colonocytes and HCT116 colon cancer cells after incubation for 24 
hours with deoxycholic acid based on a Western blot analysis. ERK, ex-
tracellular signal-regulated kinase.
  0  0  20  250    (μM)
ERK (C-20)
Colonocytes
HCT116
0 hr 24 hr
Fig. 7. Comparison of the change in the cyclin D1 protein in human 
colonocytes and HCT116 colon cancer cells after incubation for 24 
hours with deoxycholic acid based on a Western blot analysis. ERK, 
extracellular signal-regulated kinase.Journal of the Korean Society of
Coloproctology
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G1 phase). In colon cancer cells, cyclin E (necessary for G1→ 
S phase change) expression was increased, stimulating cell DNA 
fusion. However, in normal large-intestine epithelial cells, DCA 
did not show any effect on cyclin E expression. DCA also did 
not affect the expression of CDK2, which combines with cyclin 
E and becomes a phosphorylase. In normal large-intestine epi-
thelial cells, a low concentration of DCA increases expression 
of cyclin A (combines with CDK2 and CDK1 of the S phase 
and becomes a phosphorylase) and causes cell proliferation. 
At a high concentration of DCA, CDK2 expression and acti-
vation of CDK2 phosp horylase are reduced, suppressing cell 
proliferation.
In large-intestine cancer cells, DCA increases the expression 
of cyclin E (necessary for entering the S phase from the G1 
phase), which facilitates DNA synthesis and stimulates cell 
proliferation. On the other hand, a low concentration of DCA 
in normal large-intestine epithelial cells shows increased ex-
pression of cyclin A, which activates phosphorylase by fusing 
with S phase CDK2 and S phase CDK1, thus showing a cell 
proliferation effect. For high concentrations of DCA, cycline 
E, which is essential to going from the G1 phase to the S phase 
and to the expression of activated CDK2 combined with cy-
cline E, is suppressed, and activation of CDK2 phosphorylase 
is reduced, thus suppressing cell proliferation.
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